首页 › 基金 › DEERFIELD MANAGEMENT COMPANY, L.P. › MNPR
DEERFIELD MANAGEMENT COMPANY, L.P. 对 MNPR 的持仓历史
MONOPAR THERAPEUTICS INC · 医疗保健
DEERFIELD MANAGEMENT COMPANY, L.P. 在 Q2 2026 的 13F 申报中披露持有 MNPR(MONOPAR THERAPEUTICS INC)323,745 股,市值约 US$30.0M,约占其申报组合的 0.38%,在其申报持仓中市值排名第 49 位。 DEERFIELD MANAGEMENT COMPANY, L.P. 最近 4 个申报季度中有 4 个季度披露了 MNPR 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR
DEERFIELD MANAGEMENT COMPANY, L.P. 对 MNPR 的持仓演变
DEERFIELD MANAGEMENT COMPANY, L.P. 于 Q3 2025 首次披露 MNPR 持仓:159,765 股(约 US$13.0M)。 该持仓在 Q2 2026 达到峰值 323,745 股,市值约 US$30.0M。 在 4 次申报中,DEERFIELD MANAGEMENT COMPANY, L.P. 2 次增持、0 次减持、1 次保持不变。 最近一期申报(Q2 2026)显示持股 323,745 股、市值约 US$30.0M。 持仓曾出现大幅变动:Q1 2026 增持约 90% (随后一个季度股价上涨 69%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 159.76K | $13.05M | 新进 |
| Q4 2025 | 170.56K | $11.14M | 增持 |
| Q1 2026 | 323.75K | $17.74M | 增持 |
| Q2 2026 | 323.75K | $29.98M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MNPR 与 13F 数据
MNPR(MONOPAR THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 84 只申报持有 MNPR,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$61.8M), Saturn V Capital Management LP (US$28.9M), Siren, L.L.C. (US$25.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MNPR 的基金
- RA CAPITAL MANAGEMENT, L.P. 667.21K 股 · $61.78M · Q2 2026
- Saturn V Capital Management LP 311.98K 股 · $28.89M · Q2 2026
- Siren, L.L.C. 270.12K 股 · $25.01M · Q2 2026
- ADAR1 Capital Management, LLC 217.59K 股 · $20.15M · Q2 2026
- TCG Crossover Management, LLC 203.33K 股 · $18.83M · Q2 2026
- Vivo Capital, LLC 90.50K 股 · $8.38M · Q2 2026
- Ikarian Capital, LLC 47.86K 股 · $4.43M · Q2 2026
- STEMPOINT CAPITAL LP 30.12K 股 · $2.79M · Q2 2026
- Ishara Investments LP 12.30K 股 · $1.14M · Q2 2026
- Martin Investment Management, LLC 2.33K 股 · $215.46K · Q2 2026
更多关于 DEERFIELD MANAGEMENT COMPANY, L.P.
常见问题
How long has DEERFIELD MANAGEMENT COMPANY, L.P. held MNPR?
DEERFIELD MANAGEMENT COMPANY, L.P. has disclosed MNPR holdings in 4 of the last 4 reported quarters, going back to Q3 2025.
What is DEERFIELD MANAGEMENT COMPANY, L.P.'s current position in MNPR?
As of Q2 2026, DEERFIELD MANAGEMENT COMPANY, L.P. holds 323.75K shares of MNPR (MONOPAR THERAPEUTICS INC), valued at $29.98M, representing 0.38% of its reported portfolio and ranking #49.
Has DEERFIELD MANAGEMENT COMPANY, L.P. been buying or selling MNPR?
In the latest 13F filing (Q2 2026), DEERFIELD MANAGEMENT COMPANY, L.P. held unchanged its position in MNPR. The position peaked in Q2 2026 at 323.75K shares.
Which other funds hold MNPR?
Other major institutional holders of MNPR include RA CAPITAL MANAGEMENT, L.P., Saturn V Capital Management LP, Siren, L.L.C., among 84 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.